CN1541678A - Mastoplasia treating medicine - Google Patents

Mastoplasia treating medicine Download PDF

Info

Publication number
CN1541678A
CN1541678A CNA2003101050495A CN200310105049A CN1541678A CN 1541678 A CN1541678 A CN 1541678A CN A2003101050495 A CNA2003101050495 A CN A2003101050495A CN 200310105049 A CN200310105049 A CN 200310105049A CN 1541678 A CN1541678 A CN 1541678A
Authority
CN
China
Prior art keywords
medicine
radix
rhizoma
fructus
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2003101050495A
Other languages
Chinese (zh)
Other versions
CN1240419C (en
Inventor
英 徐
徐英
刘相军
徐权
邓雅静
徐桂凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2003101050495A priority Critical patent/CN1240419C/en
Publication of CN1541678A publication Critical patent/CN1541678A/en
Application granted granted Critical
Publication of CN1240419C publication Critical patent/CN1240419C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The medicine for treating hyperplasia of mammary glands consists of 19 kinds of Chinese medicinal materials, including bupleurum root, angelica, etc. as basic components, and has other components added to adapt various disease symptoms caused by different causes, such as getting angry, menstruation, climacterium and tumor. The medicine is ultraviolet ray sterilized before grinding.

Description

The medicine of treatment cyclomastopathy
Technical field
The present invention relates to a kind of medicine for the treatment of cyclomastopathy, belong to Chinese medicine.
Background technology
The cyclomastopathy traditional Chinese medical science also claims " nodules of the breast ", is the commonly encountered diseases of female mammary gland disease, is more common in 30-50 year middle-aged women, and its sickness rate accounts for 78% of whole mastopathy, and the probability that should the disease secondary become breast carcinoma than the high 4-6 of general women doubly.For the present domestic most employing RUPIXIAO of the treatment of primary disease, RUHE SANJIE PIAN, poor effect, and recurrence easily.Doctor trained in Western medicine adopts not fragrant sheet treatment of former times of citron acidify mostly, poor effect, and cause side effect such as menoxenia, leucocytes reduction easily, the generation of Breast Cancer Prevention.
Summary of the invention
Purpose of the present invention is exactly to provide a kind of medicine for the treatment of cyclomastopathy for the problem that solves the existence of treatment cyclomastopathy.
Purpose of the present invention reaches by following medicine:
This medicine is made by following materials of weight proportions: Radix Bupleuri 1, Radix Angelicae Sinensis 1, Radix Paeoniae Rubra 1, Cortex Moutan 1, Fructus Aurantii 1, Semen Vaccariae 1, Thallus Laminariae (Thallus Eckloniae) 1, Squama Manis 2/3, Sargassum 1, Rhizoma Chuanxiong 1, Cornu Cervi Pantotrichum 1/3, Rhizoma Cyperi 1, Fructus Forsythiae 1.5, ocean Huo Ye 1, Fructus Toosendan 1, Herba Hedyotidis Diffusae 1, Fructus Trichosanthis 1, Poria 1, Flos Chrysanthemi 1.
Purpose of the present invention can also reach by following medicine:
On original proportioning basis, increase Semen Persicae 1, Flos Carthami 1.
On original proportioning basis, increase Radix Rehmanniae Preparata 1, Herba Cistanches 1.
On original proportioning basis, increase Radix Codonopsis 1.5, Semen Ziziphi Spinosae 1, rhizoma sparganic 1, Rhizoma Curcumae 1.
The method for preparing above-mentioned medicine is each composition to be mixed by proportioning grind into powder after 15 minutes through conventional disinfection by ultraviolet light.
The present invention has following advantage:
1, improves the cure rate of cyclomastopathy, reduce relapse rate, have the effect of regulating the whole body endocrine regulation.
2, instant effect, safely, have no side effect.
3, the medicine source is extensive, and cost is low, taking convenience.
The specific embodiment
Embodiment 1
Prescription 1
Radix Bupleuri 15g, Radix Angelicae Sinensis 15g, Radix Paeoniae Rubra 15g, Cortex Moutan 15g, Fructus Aurantii 15g, Semen Vaccariae 15g, Thallus Laminariae (Thallus Eckloniae) 15g, Squama Manis 10g, Sargassum 15g, Rhizoma Chuanxiong 15g, Cornu Cervi Pantotrichum 5g, Rhizoma Cyperi 15g, Fructus Forsythiae 22.5g, ocean Huo Ye 15g, Fructus Toosendan 15g, Herba Hedyotidis Diffusae 15g, Fructus Trichosanthis 15g, Poria 15g, Flos Chrysanthemi 15g.The uviol lamp sterilization is ground into powder and is formed.
Function: dispersing the stagnated live-QI to relieve the stagnation of QI, dissipating phlegm and resolving masses.Radix Bupleuri, Rhizoma Cyperi, Fructus Aurantii, the circulation of qi promoting of Flos Chrysanthemi soothing liver-QI in the side; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Squama Manis, Semen Vaccariae, blood circulation promoting and dispersing pathogen accumulation, pain relieving; Fructus Trichosanthis reduces phlegm; Thallus Laminariae (Thallus Eckloniae), Sargassum, Fructus Forsythiae, eliminating stagnation; Cornu Cervi Pantotrichum the kidney invigorating, accent dash appoints; The Herba Hedyotidis Diffusae antitumaous effect; Ocean Huo Ye has the male sample effect that swashs.
Indication: have bilateral or one-sided cyclomastopathy increases the weight of when anger.
Instructions of taking: one time 6 gram, a twice-daily, boiled water is taken after mixing it with water, and one month is a course of treatment.
Curative effect: table 1
Group ????n Clinical recovery Effectively Invalid Total effective rate
??n ??% ????n ??% ????n ????% ????n ????%
The treatment group ??120 ??105 ??87.5 ????13 ??10.80 ????2 ????1.67 ????118 ????98
Matched group ??80 ??44 ??55 ????15 ??18.75 ????22 ????27.50 ????59 ????73.75
As seen from Table 1, taking prescription 1 cure rate is 87.50%, and matched group is 55.00%, and total effective rate treatment group is 98.00%, and matched group is 73.75%, through check, two groups of total effective rate significant differences, X 2=26.14, P<0.01.
Case (choosing): Guo Hongyan, woman, 32 years old, first visit in February, 1999, primary symptom bilateral breast pain 5 years, increased the weight of in nearly 1 year, bilateral breast is gone up quadrant outward can touch the lamellar enclosed mass, and matter is hard, fidgety irritability, through more so preceding, menoxenia, noctovisor scan, bilateral breast cyclomastopathy.Take prescription 1 treatment two weeks, distending pain of the breast, touching a tender spot obviously alleviates, and symptom did not have in 1 month, continued and obeyed 1 month to consolidate curative effect.
Embodiment 2
Prescription 2
On the basis of prescription 1, increase Semen Persicae 15g, Flos Carthami 15g.
Function: activating QI to eliminate phlegm, eliminating stasis and resolving masses, Semen Persicae, Flos Carthami promoting blood flow to regulate menstruation.
Indication: cyclomastopathy increases the weight of before menstruation
Instructions of taking: the same.
Curative effect: table 2
Group ??n Clinical recovery Effectively Invalid Total effective rate
??n ??% ??n ??% ??n ????% ??n ????%
The treatment group ??108 ??96 ??88.9 ??8 ??7.40 ??2 ????1.85 ??106 ????98.15
Matched group ??70 ??35 ??50 ??7 ??10 ??28 ????40 ??42 ????60
As seen from Table 2, prescription 2 cure rates are 88.90%, matched group 50.00%, and total effective rate treatment group is 98.15%, matched group is 60.00%, through check, two groups of total effective rate significant differences, X 2=41.43, P<0.01.
Case (choosing): huge refined China, woman, 24 years old, first visit in March calendar year 2001, both sides distending pain of the breast, two nipples are touched a tender spot and are obviously shown, the big lamellar tuberosity of two outer quadrants, quality is harder, through preceding pain unbearably, the time dysmenorrhea arranged, the photography of bilateral breast molybdenum palladium, bilateral breast glandular hyperplasia, with prescription 2 treatments one month, transference cure serve on 2 months, to consolidate curative effect.
Embodiment 3
Prescription 3
On the basis of prescription 1, increase Radix Rehmanniae Preparata 15g, Herba Cistanches 15g.
Function: enrich blood YIN nourishing, benefit of Chong and Ren Meridians regulating, liver and kidney tonifying, Radix Rehmanniae Preparata is smart, the Herba Cistanches kidney-replenishing.
Indication: the cyclomastopathy during climacteric
Instructions of taking: the same.
Curative effect: table 3
Group ??n Clinical recovery Effectively Invalid Total effective rate
??n ??% ????n ??% ??n ??% ?n ??%
The treatment group ??112 ??99 ??88.39 ????11 ??9.82 ??2 ??1.79 ?110 ??98.21
Matched group ??100 ??51 ??51 ????10 ??10 ??39 ??39 ?61 ??61
As seen from Table 3, prescription 3 cure rates are 88.39%, matched group 51.00%, and total effective rate prescription 3 is 98.21%, matched group is 61.00%, through check X 2=44.55, P<0.01.
Case (choosing): Sun Yanjun, woman, 49 years old, first visit in June, 2000, both sides distending pain of the breast, the outer big lamellar tuberosity of bilateral, painful irregular, during two oxter distending pain is arranged, with vexed, the irritability sweating, color ultrasound is shown the bilateral breast hypertrophy, the attached cyclomastopathy of bilateral obviously alleviates with prescription 3 treatment two weeks symptoms, continues and obeys 2 months to consolidate curative effect.
Embodiment 4
Prescription 4
On the basis of prescription 1, increase Radix Codonopsis 22.50g, Semen Ziziphi Spinosae 15g, rhizoma sparganic 15g, Rhizoma Curcumae 15g.
Function: invigorating spleen and nourishing heart, calm the nerves the QI invigorating eliminating stagnation; The Radix Codonopsis spleen reinforcing, Semen Ziziphi Spinosae is calmed the nerves, rhizoma sparganic, Rhizoma Curcumae removing blood stasis repercussive.
Indication: be applicable to for many years cyclomastopathy and the hard person of lump
Instructions of taking: the same.
Curative effect: table 4
Group ??n Clinical recovery Effectively Invalid Total effective rate
??n ??% ??n ??% ??n ??% ??n ??%
The treatment group ??120 ??107 ??89.17 ??11 ??9.17 ??2 ??1.67 ??118 ??98.33
Matched group ??95 ??47 ??49.47 ??13 ??13.68 ??35 ??36.84 ??60 ??63.16
As seen from Table 4, the treatment cure rate of prescription 4 is 89.17%, matched group 49.47%, and total effective rate prescription 4 is 98.33%, matched group is 63.16%, through check X 2=43.16, P<0.01.Case (choosing): Wang Jianjun, woman, 32 years old, first visit in March, 1999, bilateral breast show effect surplus the distending pain 10 year repeatedly, and bilateral breast is gone up the big lamellar tuberosity of quadrant outward, the time have vexed, bitter taste, eye to do, with losing the eye dreaminess, unable, the molybdenum palladium shows bilateral breast severe hypertrophy, through prescription 4 treatments one month, the obvious deliquescing of bilateral breast lump, surplus transference cure continues and obeys one month with after treatment.

Claims (5)

1, a kind of medicine for the treatment of cyclomastopathy is characterized in that being made by following materials of weight proportions: Radix Bupleuri 1, Radix Angelicae Sinensis 1, Radix Paeoniae Rubra 1, Cortex Moutan 1, Fructus Aurantii 1, Semen Vaccariae 1, Thallus Laminariae (Thallus Eckloniae) 1, Squama Manis 2/3, Sargassum 1, Rhizoma Chuanxiong 1, Cornu Cervi Pantotrichum 1/3, Rhizoma Cyperi 1, Fructus Forsythiae 1.5, ocean Huo Ye 1, Fructus Toosendan 1, Herba Hedyotidis Diffusae 1, Fructus Trichosanthis 1, Poria 1, Flos Chrysanthemi 1.
2,, it is characterized in that on original proportioning basis, increasing Semen Persicae 1, Flos Carthami 1 according to the said medicine of claim 1.
3,, it is characterized in that on original proportioning basis, increasing Radix Rehmanniae Preparata 1, Herba Cistanches 1 according to the said medicine of claim 1.
4,, it is characterized in that on original proportioning basis, increasing Radix Codonopsis 1.5, Semen Ziziphi Spinosae 1, rhizoma sparganic 1, Rhizoma Curcumae 1 according to the said medicine of claim 1.
5, the method for preparing the said medicine of claim 1 is characterized in that each composition is ground into powder after 15 minutes through conventional disinfection by ultraviolet light by the proportioning mixing.
CNB2003101050495A 2003-11-07 2003-11-07 Mastoplasia treating medicine Expired - Fee Related CN1240419C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2003101050495A CN1240419C (en) 2003-11-07 2003-11-07 Mastoplasia treating medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2003101050495A CN1240419C (en) 2003-11-07 2003-11-07 Mastoplasia treating medicine

Publications (2)

Publication Number Publication Date
CN1541678A true CN1541678A (en) 2004-11-03
CN1240419C CN1240419C (en) 2006-02-08

Family

ID=34333604

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003101050495A Expired - Fee Related CN1240419C (en) 2003-11-07 2003-11-07 Mastoplasia treating medicine

Country Status (1)

Country Link
CN (1) CN1240419C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346802C (en) * 2004-11-08 2007-11-07 北京万邦医药投资有限公司 Chinese medicine composition for preventing and treating hysteromyoma and mammary gland swelling, regulating menstruation and beautifying
CN101181473B (en) * 2007-11-15 2010-12-22 普洱市民族传统医药研究所 Compound maytenfolic splinter
CN101401884B (en) * 2008-11-10 2012-05-09 贾辉 Traditional Chinese medicine decoction for treating gland hyperplasia
CN102908603A (en) * 2012-10-30 2013-02-06 王凤 Chinese medicament for treating hyperplasia of mammary glands
CN104645165A (en) * 2015-02-11 2015-05-27 赵金志 Traditional Chinese medicine for treating hyperplasia of mammary glands
CN104840804A (en) * 2015-06-15 2015-08-19 王艳娣 Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN105031545A (en) * 2015-08-28 2015-11-11 咸阳夏华中医乳腺病研究所 Orally taken traditional Chinese medicine for treating hyperplasia of mammary glands

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346802C (en) * 2004-11-08 2007-11-07 北京万邦医药投资有限公司 Chinese medicine composition for preventing and treating hysteromyoma and mammary gland swelling, regulating menstruation and beautifying
CN101181473B (en) * 2007-11-15 2010-12-22 普洱市民族传统医药研究所 Compound maytenfolic splinter
CN101401884B (en) * 2008-11-10 2012-05-09 贾辉 Traditional Chinese medicine decoction for treating gland hyperplasia
CN102908603A (en) * 2012-10-30 2013-02-06 王凤 Chinese medicament for treating hyperplasia of mammary glands
CN102908603B (en) * 2012-10-30 2014-06-18 王凤 Chinese medicament for treating hyperplasia of mammary glands
CN104645165A (en) * 2015-02-11 2015-05-27 赵金志 Traditional Chinese medicine for treating hyperplasia of mammary glands
CN104840804A (en) * 2015-06-15 2015-08-19 王艳娣 Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN105031545A (en) * 2015-08-28 2015-11-11 咸阳夏华中医乳腺病研究所 Orally taken traditional Chinese medicine for treating hyperplasia of mammary glands
CN105031545B (en) * 2015-08-28 2018-09-11 咸阳夏华中医乳腺病研究所 A kind of traditional Chinese medicine for oral administration for treating the proliferation of mammary gland

Also Published As

Publication number Publication date
CN1240419C (en) 2006-02-08

Similar Documents

Publication Publication Date Title
CN1053366C (en) Chinese herbal medicine composition
CN1060664C (en) Chinese drug for curing and preventing mastosis and its preparing method
CN1943683A (en) An external use medicinel and beauty composition for treatment of and preventing chloasma
CN1695694A (en) Chinese traditional medicine for treating breast disease and preparing technique
CN1150009C (en) Medicine for female acyesis
CN1289121C (en) Medicine for promoting ovulation and aiding pregnancy
CN1931301A (en) Chinese medicine prepn for treating mastoproliferation and its prepn process
CN1240419C (en) Mastoplasia treating medicine
CN1183919C (en) Cancer treating medical composition
CN101229302A (en) Chinese traditional medicine for treating mammary glands hyperplasia
CN1966067A (en) Medicament for treating aplastic anemia
CN102755515B (en) Traditional Chinese medicine decoction for treating hyperplasia of mammary glands
CN1709288A (en) Medicinal composition, and its preparing method and use
CN1188153C (en) Medicines for treating cancers and tumours
CN102100779A (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands by soothing liver and relieving depression
CN1054541C (en) Traditional Chinese medicine for treating mastosis
CN1285354C (en) Medicine for treating cerebral infarction
CN1169555C (en) Decocted pill medicine for treating excess syndrome of hepatitis B
CN1112208C (en) Chinese medicine for treating intraocular hemorrhage
CN1352978A (en) Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process
CN103893621A (en) Traditional Chinese medicament for treating senile vaginitis
CN1377672A (en) Rheumatic pain killing preparation
CN1059800C (en) Injection containing ginseng and astragalus root components
CN103191369A (en) Chinese medicinal composition for treating mammary gland hyperplasia
CN1883636A (en) Medicine for treating mammary gland hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060208

Termination date: 20151107

EXPY Termination of patent right or utility model